Dietary gluten increases natural killer cell cytotoxicity and cytokine secretion

European Journal of Immunology

Volumn 44, Issue 10, 2014, Pages 3056-3067

  Larsen, Jesper ^a   Dall, Morten ^a   Antvorskov, Julie Christine ^a   Weile, Christian ^a   Engkilde, Kåre ^a   Josefsen, Knud ^a   Buschard, Karsten ^a  

^a Rigshospitalet   (Denmark)

Author keywords

C56BL 6 mice; Gliadin; Gluten; NK cells; NOD mice; Type 1 diabetes

Indexed keywords

CXCL1 CHEMOKINE; GAMMA INTERFERON; GLIADIN; GLUTEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL KILLER CELL RECEPTOR NKG2D; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOID ORGAN; MORBIDITY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL LINE; CYTOTOXICITY TEST; DIET; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOLOGY; NONOBESE DIABETIC MOUSE; PATHOLOGY; SECRETION (PROCESS); TOXICITY;

ANIMALS; CELL LINE; CYTOKINES; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; DIABETES MELLITUS, TYPE 1; DIET; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GLUTENS; INSULIN-SECRETING CELLS; KILLER CELLS, NATURAL; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED NOD;

EID: 84925251178     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201344264     Document Type: Article

References (62)

1. Funda, D. P., Kaas, A., Bock, T., Tlaskalová-Hogenová, H. and Buschard, K., Gluten-free diet prevents diabetes in NOD mice. Diabetes Metab. Res. Rev. 1999. 15: 323-327.
2. Scott, F. W., Rowsell, P., Wang, G. S., Burghardt, K., Kolb, H. and Flohé, S., Oral exposure to diabetes-promoting food or immunomodulators in neonates alters gut cytokines and diabetes. Diabetes 2002. 51: 73-78.
3. Graham, S., Courtois, P., Malaisse, W., Rozing, J., Scott, F. and Mowat, A. M. I., Enteropathy precedes type 1 diabetes in the BB rat. Gut 2004. 53: 1437-1444.
4. Secondulfo, M., Iafusco, D., Carratu, R., deMagistris, L., Sapone, A., Generoso, M., Mezzogiorno, A. et al., Ultrastructural mucosal alterations and increased intestinal permeability in non-celiac, type I diabetic patients. Dig. Liver Dis. 2004. 36: 35-45.
5. Smyth, D. J., Plagnol, V., Walker, N. M., Cooper, J. D., Downes, K., Yang, J. H., Howson, J. M. et al., Shared and distinct genetic variants in type 1 diabetes and celiac disease. New Engl. J. Med. 2008. 359: 2767-2777.
6. Buschard, K., What causes type 1 diabetes? Lessons from animal models. Apmis 2011. 119: 1-19.
7. Cosnes, J., Cellier, C., Viola, S., Colombel, J. F., Michaud, L., Sarles, J., Hugot, J. P. et al., Incidence of autoimmune diseases in celiac disease: protective effect of the gluten-free diet. Clin. Gastroenterol. Hepatol. 2008. 6: 753-758.
8. Sildorf, S. M., Fredheim, S., Svensson, J. and Buschard, K., Remission without insulin therapy on gluten-free diet in a 6-year old boy with type 1 diabetes mellitus. BMJ Case Rep. 2012. DOI: 10.1136/bcr.02.2012.5878.
9. Dall, M., Calloe, K., Haupt-Jorgensen, M., Larsen, J., Schmitt, N., Josefsen, K. and Buschard, K., Gliadin fragments and a specific gliadin 33-mer peptide close KATP channels and induce insulin secretion in INS-1E cells and rat islets of Langerhans. PLoS One 2013. 8: e66474.
10. Aaen, K., Rygaard, J., Josefsen, K., Petersen, H., Brogren, C. H., Horn, T. and Buschard, K., Dependence of antigen expression on functional state of β-cells. Diabetes 1990. 39: 697-701.
11. Antvorskov, J. C., Fundova, P., Buschard, K. and Funda, D. P., Impact of dietary gluten on regulatory T cells and Th17 cells in BALB/c mice. PLoS One 2012. 7: e33315.
12. Palová-Jelínková, L., Rožková, D., Pecharová, B., Bártová, J., Šedivá, A., Tlaskalová-Hogenová, H., Spíšek, R. et al., Gliadin fragments induce phenotypic and functional maturation of human dendritic cells. J. Immunol. 2005. 175: 7038-7045.
13. Junker, Y., Leffler, D. A., Wieser, H. and Schuppan, D., M2022 gliadin activates monocytes, macrophages and dendritic cells in vitro and in vivo via Toll like receptor 4. Gastroenterology 2009. 136: A-468-A-468.
14. Terrazzano, G., Sica, M., Gianfrani, C., Mazzarella, G., Maurano, F., De Giulio, B., de Saint-Mezard, S. et al., Gliadin regulates the NK-dendritic cell cross-talk by HLA-E surface stabilization. J. Immunol. 2007. 179: 372-381.
15. Flodström, M., Shi, F. D., Sarvetnick, N. and Ljunggren, H. G., The natural killer cell-friend or foe in autoimmune disease? Scand. J. Immunol. 2002. 55: 432-441.
16. Dotta, F., Censini, S., van Halteren, A. G., Marselli, L., Masini, M., Dionisi, S., Mosca, F. et al., Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc. Natl. Acad. Sci. USA 2007. 104: 5115-5120.
17. Brauner, H., Elemans, M., Lemos, S., Broberger, C., Holmberg, D., Flodström-Tullberg, M., Kärre, K. et al., Distinct phenotype and function of NK cells in the pancreas of nonobese diabetic mice. J. Immunol. 2010. 184: 2272-2280.
18. Johansson, S. E., Hall, H., Björklund, J. and Höglund, P., Broadly impaired NK cell function in non-obese diabetic mice is partially restored by NK cell activation in vivo and by IL-12/IL-18 in vitro. Int. Immunol. 2004. 16: 1-11.
19. Poulton, L. D., Smyth, M. J., Hawke, C. G., Silveira, P., Shepherd, D., Naidenko, O. V., Godfrey, D. I. et al., Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice. Int. Immunol. 2001. 13: 887-896.
20. Rodacki, M., Svoren, B., Butty, V., Besse, W., Laffel, L., Benoist, C. and Mathis, D., Altered natural killer cells in type 1 diabetic patients. Diabetes 2007. 56: 177-185.
21. MacKay, P., Jacobson, J. and Rabinovitch, A., Spontaneous diabetes mellitus in the bio-breeding/Worcester rat. Evidence in vitro for natural killer cell lysis of islet cells. J. Clin. Invest. 1986. 77: 916.
22. Akamura, N., Woda, B. A., Tafuri, A., Greiner, D. L., Reynolds, C. W., Ortaldo, J., Chick, W. et al., Intrinsic cytotoxicity of natural killer cells to pancreatic islets in vitro. Diabetes 1990. 39: 836-843.
23. Gur, C., Enk, J., Kassem, S. A., Suissa, Y., Magenheim, J., Stolovich-Rain, M., Nir, T. et al., Recognition and killing of human and murine pancreatic β cells by the NK receptor NKp46. J. Immunol. 2011. 187: 3096-3103.
24. Gur, C., Porgador, A., Elboim, M., Gazit, R., Mizrahi, S., Stern-Ginossar, N., Achdout, H. et al., The activating receptor NKp46 is essential for the development of type 1 diabetes. Nat. Immunol. 2009. 11: 121-128.
25. Flodström, M., Maday, A., Balakrishna, D., Cleary, M. M., Yoshimura, A. and Sarvetnick, N., Target cell defense prevents the development of diabetes after viral infection. Nat. Immunol. 2002. 3: 373-382.
26. Beilke, J. N., Meagher, C. T., Hosiawa, K., Champsaur, M., Bluestone, J. A. and Lanier, L. L., NK cells are not required for spontaneous autoimmune diabetes in NOD mice. PLoS One 2012. 7: e36011.
27. Lee, I.-F., Qin, H., Trudeau, J., Dutz, J. and Tan, R., Regulation of autoimmune diabetes by complete Freund's adjuvant is mediated by NK cells. J. Immunol. 2004. 172: 937-942.
28. Miyazaki, J., Araki, K., Yamato, E., Ikegami, H., Asano, T., Shibasaki, Y., Oka, Y. et al., Establishment of a pancreatic β cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology 1990. 127: 126-132.
29. Chensue, S. W., Warmington, K. S., Ruth, J. H., Sanghi, P. S., Lincoln, P. and Kunkel, S. L., Role of monocyte chemoattractant protein-1 (MCP-1) in Th1 (mycobacterial) and Th2 (schistosomal) antigen-induced granuloma formation: relationship to local inflammation, Th cell expression, and IL-12 production. J. Immunol. 1996. 157: 4602-4608.
30. Morrison, B. E., Park, S. J., Mooney, J. M. and Mehrad, B., Chemokine-mediated recruitment of NK cells is a critical host defense mechanism in invasive aspergillosis. J. Clin. Invest. 2003. 112: 1862-1870.
31. Nakano, H., Lin, K. L., Yanagita, M., Charbonneau, C., Cook, D. N., Kakiuchi, T. and Gunn, M. D., Blood-derived inflammatory dendritic cells in lymph nodes stimulate acute T helper type 1 immune responses. Nat. Immunol. 2009. 10: 394-402.
32. Piemonti, L., Leone, B. E., Nano, R., Saccani, A., Monti, P., Maffi, P., Bianchi, G. et al., Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation. Diabetes 2002. 51: 55-65.
33. Sutherland, R., Delia, D., Schneider, C., Newman, R., Kemshead, J. and Greaves, M., Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin. Proc. Natl. Acad. Sci. USA 1981. 78: 4515-4519.
34. Shipkova, M. and Wieland, E., Surface markers of lymphocyte activation and markers of cell proliferation. Clin. Chim. Acta 2012. 413: 1338-1349.
35. Piper, J. L., Gray, G. M. and Khosla, C., Effect of prolylendopeptidase on digestive-resistant gliadin peptides in vivo. J. Pharmacol. Exp. Ther. 2004. 311: 213-219.
36. Schumann, M., Richter, J. F., Wedell, I., Moos, V., Zimmermann-Kordmann, M., Schneider, T., Daum, S. et al., Mechanisms of epithelial translocation of the α2-gliadin-33mer in coeliac sprue. Gut 2008. 57: 747-754.
37. Drago, S., El Asmar, R., Di Pierro, M., Grazia Clemente, M., Sapone, A. T. A., Thakar, M., Iacono, G. et al., Gliadin, zonulin and gut permeability: effects on celiac and non-celiac intestinal mucosa and intestinal cell lines. Scand. J. Gastroenterol. 2006. 41: 408-419.
38. Tagliabue, A., Befus, A., Clark, D. and Bienenstock, J., Characteristics of natural killer cells in the murine intestinal epithelium and lamina propria. J. Exp. Med. 1982. 155: 1785-1796.
39. Fasano, A., Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol. Rev. 2011. 91: 151-175.
40. Rescigno, M. and Di Sabatino, A., Dendritic cells in intestinal homeostasis and disease. J. Clin. Invest. 2009. 119: 2441-2450.
41. Hänninen, A., Jaakkola, I. and Jalkanen, S., Mucosal addressin is required for the development of diabetes in nonobese diabetic mice. J. Immunol. 1998. 160: 6018-6025.
42. Coppieters, K., Amirian, N. and von Herrath, M., Intravital imaging of CTLs killing islet cells in diabetic mice. J. Clin. Invest. 2012. 122: 119.
43. Chirdo, F., Rumbo, M., Anon, M. and Fossati, C., Presence of high levels of non-degraded gliadin in breast milk from healthy mothers. Scand. J. Gastroenterol. 1998. 33: 1186-1192.
44. Fauriat, C., Long, E. O., Ljunggren, H.-G. and Bryceson, Y. T., Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood 2010. 115: 2167-2176.
45. Kanevskiy, L. M., Telford, W. G., Sapozhnikov, A. M. and Kovalenko, E. I., Lipopolysaccharide induces IFN-γ production in human NK cells. Front. Immunol. 2013. 4: 11.
46. Garay-Malpartida, H. M., Mourão, R. F., Mantovani, M., Santos, I. A., Sogayar, M. C. and Goldberg, A. C., Toll-like receptor 4 (TLR4) expression in human and murine pancreatic beta-cells affects cell viability and insulin homeostasis. BMC Immunol. 2011. 12: 18.
47. Lammers, K. M., Lu, R., Brownley, J., Lu, B., Gerard, C., Thomas, K., Rallabhandi, P. et al., Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology 2008. 135: 194-204.e3.
48. Eisenhardt, M., Glässner, A., Krämer, B., Körner, C., Sibbing, B., Kokordelis, P., Nischalke, H. D. et al., The CXCR3 (+) CD56bright phenotype characterizes a distinct NK cell subset with anti-fibrotic potential that shows dys-regulated activity in hepatitis C. PLoS One 2012. 7: e38846.
49. Junker, Y., Zeissig, S., Kim, S.-J., Barisani, D., Wieser, H., Leffler, D. A., Zevallos, V. et al., Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of Toll-like receptor 4. J. Exp. Med. 2012. 209: 2395-2408.
50. Buschard, K., Aaen, K., Horn, T., Damme, J. V. and Bendtzen, K., Interleukin 6: a functional and structural in vitro modulator of beta-cells from islets of Langerhans. Autoimmunity 1990. 5: 185-194.
51. Funda, D. P., Kaas, A., Tlaskalová-Hogenová, H. and Buschard, K., Gluten-free but also gluten-enriched (gluten+) diet prevent diabetes in NOD mice; the gluten enigma in type 1 diabetes. Diabetes Metab. Res. Rev. 2008. 24: 59-63.
52. Hansen, C. H., Krych, L., Buschard, K., Metzdorff, S. B., Nellemann, C., Hansen, L. H., Nielsen, D. S. et al., A maternal gluten-free diet reduces inflammation and diabetes incidence in the offspring of NOD mice. Diabetes 2014. 63: 2821-2832.
53. Qin, H., Lee, I.-F., Panagiotopoulos, C., Wang, X., Chu, A. D., Utz, P. J., Priatel, J. J. et al., Natural killer cells from children with type 1 diabetes have defects in NKG2D-dependent function and signaling. Diabetes 2011. 60: 857-866.
54. Ogasawara, K., Hamerman, J. A., Hsin, H., Chikuma, S., Bour-Jordan, H., Chen, T., Pertel, T. et al., Impairment of NK cell function by NKG2D modulation in NOD mice. Immunity 2003. 18: 41-51.
55. Lorini, R., Moretta, A., Valtorta, A., d'Annunzio, G., Cortona, L., Vitali, L., Bozzola, M. et al., Cytotoxic activity in children with insulin-dependent diabetes mellitus. Diabetes Res. Clin. Pract. 1994. 23: 37-42.
56. Ogasawara, K., Hamerman, J. A., Ehrlich, L. R., Bour-Jordan, H., Santamaria, P., Bluestone, J. A. and Lanier, L. L., NKG2D blockade prevents autoimmune diabetes in NOD mice. Immunity 2004. 20: 757-767.
57. Zitvogel, L., Dendritic and natural killer cells cooperate in the control/switch of innate immunity. J. Exp. Med. 2002. 195: F9-F14.
58. Antvorskov, J. C., Josefsen, K., Engkilde, K., Funda, D. P. and Buschard, K., Dietary gluten and the development of type 1 diabetes. Diabetologia 2014. In press. DOI: 10.1007/s00125-014-3265-1
59. Antvorskov, J. C., Fundova, P., Buschard, K. and Funda, D. P., Dietary gluten alters the balance of proinflammatory and anti-inflammatory cytokines in T cells of BALB/c mice. Immunology. 2013. 138: 23-33.
60. Catassi, C., Bai, J. C., Bonaz, B., Bouma, G., Calabrò, A., Carroccio, A., Castillejo, G. et al., Non-celiac gluten sensitivity: the new frontier of gluten related disorders. Nutrients 2013. 5: 3839-3853.
61. Adlercreutz, E. H., Weile, C., Larsen, J., Engkilde, K., Agardh, D., Buschard, K. and Antvorskov, J. C., A gluten free diet lowers NKG2D and ligand expression in BALB/c and NOD mice. Clin. Exp. Immunol. 2014. 177: 391-403.
62. Alter, G., Malenfant, J. M. and Altfeld, M., CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods 2004. 294: 15-22.